Skip to main content
STS 2024 Annual Meeting Main banner
Back

Adult Cardiac

Late Breaker: SAVR vs. TAVR in Low Risk Patients...What's the Data So Far?

Panel Discussion and Audience Q&A

Monday, January 29, 2024
7:55 AM – 8:45 AM CT
Location: 304ABC

    Panelist(s)

  • Michael J. Reardon, MD

    Faculty
    Houston Methodist DeBakey Heart & Vascular Center
    Houston, Texas, United States

    Disclosure(s): AstraZeneca; Boston Scientific; Cook Medical; Ethicon; Merck & Co., Inc., Rahway, NJ, USA; Novartis; BMS: Consultant (Ongoing)

  • Michael Mack, MD

    Chair Cardiovascular Service Line
    Baylor Scott & White Health
    Plano, Texas, United States

    Disclosure(s): Carmat: Corporate Board Member (Ongoing); Edwards Lifesciences: Trial Co-PI (Ongoing); Medtronic: Study Chair (Ongoing)

  • Vinay Badhwar, MD

    Professor and Chair, Department of Cardiovascular and Thoracic Surgery
    West Virginia University
    Morgantown, West Virginia, United States

    Disclosure(s): No financial relationships to disclose

  • Vinod H. Thourani, MD

    Marcus Chairman of Cardiovascular Surgery
    Piedmont Heart Institute and Piedmont Healthcare
    Atlanta, Georgia, United States

    Disclosure(s): Abbott Vascular: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Artivion: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); AtriCure: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Advisory Board (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)